Stay updated with breaking news from Demonstrates Potential. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Preclinical Data Demonstrate EDP-235's Superior Target Tissue Distribution and Cell Penetration Compared to Other Protease Inhibitors New Preclinical Pharmacokinetic Data Highlight EDP-323's
Preclinical Data Demonstrate EDP-235’s Superior Target Tissue Distribution and Cell Penetration Compared to Other Protease InhibitorsNew Preclinical Pharmacokinetic Data Highlight EDP-323’s Strong Bioavailability and Favorable Tissue TargetingWATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ: E...
Enanta Pharmaceuticals, Inc. , a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that data for EDP-235, its lead 3CL protease... | April 5, 2023
/PRNewswire/ -- The "Limestone: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Limestone Market to Reach...
Schaefer Kalk GmbH & Co KG (Germany) Sumitomo Osaka Cement Co., Ltd. (Japan) Taiheiyo Cement Group (Japan) UBE Material Industries, Ltd. (Japan) 3. MARKET TRENDS & DRIVERS Limestone Shipments Poised to Grow Buoyed by Positive Outlook for World Construction Industry Rising Commercial Real Estate Investments Lends Traction to Market Growth Large Investments on Infrastructure Development Boost Demand Rising Demand for Cement and the Corresponding Increase in Production Drives Limestone Consumption Critical Importance of Lime in Steel Production Helps Sustain Momentum Paper Industry: Larg...